Search

everythinglearnresearchcommunity

for

Search:↓

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Certain Dibenzo derivatives may help treat prostate cancer.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Certain gene variations are significantly linked to hair loss, especially in white people.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Endocrine disruptors may cause early hair loss.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

A new compound, 3a, effectively fights prostate cancer better than finasteride.